Xerostomia Therapeutics Market Size

Xerostomia Therapeutics Market size was valued at USD 2.06 billion in 2023 and is expected to reach USD 3.39 billion by the end of 2036, expanding at around 3.9% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of xerostomia therapeutics is assessed at USD 2.12 billion.

The increase in adoption of radiation therapy and chemotherapy is likely to lead to an increased incidence of xerostomia, which is estimated to predominantly drive the xerostomia therapeutics market. Other factors driving the market growth include increasing usage of prescription medicines, easy availability and cost-effectiveness of medicines, growing geriatric population base and increasing prevalence of diseases, such as Sjogren’s syndrome, HIV, diabetes, and Alzheimer’s disease, among other diseases.  According to the Centres for Disease Control & Prevention (CDC), every year about 650,000 cancer patients receive chemotherapy in an outpatient oncology clinic.